*Some Market data delayed by 15 mins.

Enveric Biosciences, Inc. Common Stock

Symbol: ENVB (NASDAQ)
0.00 ▼ (-100.00%) -0.821

Company Description:
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $0.8214
  • Yesterday High: $0.8599
  • Yesterday Low: $0.8081
  • Yesterday Volume: 112.63K
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: Enveric Biosciences, Inc. Common Stock
  • Website: https://www.enveric.com
  • Listed Date: 1995-08-24
  • Location: NAPLES, FL
  • Market Status: Active
  • CIK Number: 0000890821
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $6.37M
  • Round Lot: 100
  • Outstanding Shares: 7.75M
  • Asset Type: CS
RECENT FILINGS FOR ENVB
Filing DateFiling TypeFormat
2024-05-178-KView
2024-05-1510-QView
2024-05-158-KView
2024-05-03424B5View
2024-05-038-KView
2024-04-16ARSView
2024-04-16DEF 14AView
2024-03-288-KView
2024-03-268-KView
2024-03-2610-KView
2024-03-198-KView
2024-03-11424B5View
2024-03-118-KView
2024-02-298-KView
2024-02-264View
2024-02-264View
2024-02-264View
2024-02-218-KView
2024-02-14SC 13GView
2024-02-098-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.